RYTM Stock-Based Compensation
Rhythm Pharmaceuticals Inc · Stock-Based Compensation
RYTM Stock-Based Compensation
Latest reported$110.33Mperiod ending
RYTM Stock-Based Comp ($0.00 → $110.33M)
Annual stock-based compensation
High-resolution chart · PNG
RYTM stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 66,818,000 | |
| 39,682,000 | |
| 32,553,000 | |
| 19,831,000 | |
| 20,804,000 | |
| 17,455,000 | |
| 11,875,000 | |
| 6,390,000 | |
| 2,278,000 | |
| 1,168,000 | |
| 298,000 | |
| 66,000 | |
| 127,000 | |
| 0 |